Autres langues Bod Science Limited

Actions

BOD

AU0000181331

Marché Fermé - Australian S.E. Autres places de cotation 05:59:52 23/11/2023			Varia. 5j.	Varia. 1 janv.
0,024 ^AUD	-7,69 %		-.--%	-.--%

2023	Bod Science Limited conclut un accord de fourniture avec Green Farmers	CI
2023	Bod Science reçoit un remboursement d'impôt sur la recherche et le développement de 1,6 million de dollars australiens ; les actions augmentent de 8%.	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Bod Science Announces Delay in Appendix 4D Lodgement	25/03
BOD Science Signs Supply Agreement in Medicinal Cannabis with Green Farmers	13/12
Bod Science Limited Enters into Supply Agreement with Green Farmers	13/12
Bod Science Receives AU$1.6 Million R&D Tax Refund; Shares Rise 8%	22/11
Bod Expects to Receive Funds from Antah Soon	21/11
Bod Science Delays Settlement of Tranche 1 of AU$2.1 Million Placement	16/11
Bod Science Raises AU$2.1 Million Via Share Placement; Shares Fall 43%	08/11
Bod Science Limited announced that it expects to receive AUD 2.05 million in funding	08/11
Australian Shares Retreat as Monthly CPI Indicator Rises	27/09/23
Bod Science Validates Greater Bioavailability of Drug Delivery Technology; Shares Rally 12%	27/09/23
Bod Science Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30/08/23
Bod Science Limited Announces Change of Principal Place of Business	14/08/23
Bod Science Completes Acquisition of Drug Delivery Technology; Shares Up 3%	10/08/23
Bod Australia Limited completed the acquisition of Aqua Phase Ltd.	10/08/23
Bod Science Validates Bioavailability of Aqua Phase Technology	25/07/23
Bod Science Signs Letter of Intent to Sell Medical Cannabis Products in Malaysia	21/06/23
US Debt Ceiling Caution Dampens Appetite for Australian Equities	23/05/23
Bod Australia Secures Ethics Approval for Drug Delivery Study; Shares Jump 10%	23/05/23
Bod Science Limited Announces David Baker Assumes an Additional Advisory Role to Support Management to Progress A Number of Commercial Initiatives	24/04/23
BOD Science Completes Recruiting for Phase IIb Clinical Trial of CBD Product	04/04/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Bod Science Limited

Actions

BOD

AU0000181331

Autres langues

Filtres